Molecule Details
| InChIKey | ZTTKEBYSXUCBSE-QDFUAKMASA-N |
|---|---|
| Compound Name | Beclabuvir |
| Canonical SMILES | COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1[C@@H]3CC[C@H]1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.74 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12225 |
|---|---|
| Drug Name | Beclabuvir |
| CAS Number | 958002-33-0 |
| Groups | investigational |
| ATC Codes | J05AP58 |
| Description | Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic. |
Categories: Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals for treatment of HCV infections Direct Acting Antivirals Heterocyclic Compounds, Fused-Ring
Cross-references: CHEMBL4105584 ChemSpider: 27289076 PDB: 2N7 PubChem:56934415 PubChem:347828504 Wikipedia: Beclabuvir ZINC: ZINC000150340281
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P26664 | Genome polyprotein | inhibitor | targets |